ANTX

AN2 Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

14.0%

Short % Float

14.8d to cover · Moderate squeeze

75.2%

Inst % Float

10 holders · 2026-06-30

Vivo Capital, LLC

Top Holder

8.4% of float

17.0M sh

Public Float

67/100

Dilution Score

High

12 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

67/100

HIGH

Inst: 75.16% · Top: Vivo Capital, LLC

Biotech Analytics

Biotech / Pharma

20.36

Dilution Risk: HIGHSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk67

Clinical Trials12

Short Interest50